Previous studies have demonstrated that type I interferon response drives neuroinflammation and synapse loss in AD patients34, and higher levels of interferon-gamma were observed in patients with mild cognitive impairment (MCI) compared to controls35. The gene discussed is IFNG; the disease is Alzheimer disease.